<- Go Home
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Market Cap
$5.6M
Volume
530.1K
Cash and Equivalents
$10.9M
EBITDA
-$6.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$4.8M
Profit Margin
60.25%
52 Week High
$1.03
52 Week Low
$0.03
Dividend
N/A
Price / Book Value
0.56
Price / Earnings
-0.89
Price / Tangible Book Value
0.56
Enterprise Value
-$5.3M
Enterprise Value / EBITDA
0.84
Operating Income
-$6.4M
Return on Equity
66.50%
Return on Assets
-36.37
Cash and Short Term Investments
$10.9M
Debt
N/A
Equity
$9.9M
Revenue
$8.0M
Unlevered FCF
-$2.7M
Sector
Biotechnology
Category
N/A